MediMix Oncology
  • Home
  • Congresses
    • 2026
      • BSMO 50 YEARS
      • ASCO GU 2026
      • ASCO GI 2026
    • 2025
      • SABCS 2025
      • SIOG 2025
      • ESMO 2025
      • WCLC 2025
      • ESMO GI 2025
      • ASCO 2025
      • EADO 2025
      • ELCC 2025
      • ENETS 2025
  • Webinars
    • BGDO Educational webinar – 17032026
    • ESDO – GI Cancer – ASCO GI 2026
    • ESDO GI Cancer – ESMO 2025
  • Contact
  • Other specialties
    • Dermatology
    • Hematology
    • Respirology
  • SIGN UP
  • SIGN IN
    • Login
    • Account
ESMO GI 2025

Retrospective analysis of liver transplantation eligibility based on the Milan criteria in GEP NETs

24 July 2025

Presented by Dr Manon Verhé (UZ Leuven, Belgium)

Dr Manon Verhé, fellow in gastroenterology at UZ Leuven discussed the results of a single-centre retrospective study evaluating liver transplantation (LT) eligibility in 153 patients with liver metastases drawn from a cohort of 699 GEP-NET cases diagnosed between 2012 and 2024. Eligibility was assessed in two steps: initial screening using three Milan criteria (age ≤65 years, Ki-67 index <10%, and absence of extrahepatic disease), followed by full criteria evaluation. Additionally, the study assessed missed opportunities for LT by identifying patients who had at least one year of stable disease and fulfilled Milan criteria but were not considered for transplantation.

Initial screening identified 5.2% (8/153) of patients as potentially eligible; however, only 2% (3/153) met the full Milan criteria. Two patients underwent LT, and one remains under evaluation. The most frequent exclusion criterion was extrahepatic disease (90.3%), followed by age >65 years (53.5%) and Ki-67 index >10% (22.2%). These findings underscore that only a small subset of GEP-NET patients are LT candidates under current criteria, with extrahepatic disease as the principal limiting factor. Comprehensive imaging and multidisciplinary assessment remain essential in the LT evaluation process.

References:

Verhé M. et al., ESMO GI 2025, 211P

Back to ESMO GI 2025

Tags:

poster

Share Article

Website created by MediMix © 2026 - Privacy Policy

  • Home
  • Congresses
    • 2026
      • BSMO 50 YEARS
      • ASCO GU 2026
      • ASCO GI 2026
    • 2025
      • SABCS 2025
      • SIOG 2025
      • ESMO 2025
      • WCLC 2025
      • ESMO GI 2025
      • ASCO 2025
      • EADO 2025
      • ELCC 2025
      • ENETS 2025
  • Webinars
    • BGDO Educational webinar – 17032026
    • ESDO – GI Cancer – ASCO GI 2026
    • ESDO GI Cancer – ESMO 2025
  • Contact
  • Other specialties
    • Dermatology
    • Hematology
    • Respirology
  • SIGN UP
  • SIGN IN
    • Login
    • Account
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.